• musoro_banner_01

Retatrutide: Nyeredzi Inosimuka Iyo Inogona Kushandura Kufutisa uye Kurapa Chirwere Chirwere

Mumakore achangopfuura, kusimuka kweGLP-1 mishonga yakadai semaglutide uye tirzepatide yakaratidza kuti kurasikirwa kwakakosha kunokwanisika pasina kuvhiyiwa. Zvino,Retatrutide, katatu receptor agonist yakagadziridzwa naEli Lilly, iri kukwevera kutarisisa kwepasirese kubva munharaunda yezvekurapa uye vatengesi zvakafanana nekuda kwekugona kwayo kuunza zvakatokura mhedzisiro kuburikidza neyakasiyana nzira yekuita.

A Breakthrough Multi-Target Mechanism

Retatrutide inomira kunze kwayopanguva imwechete activation yematatu receptors:

  • GLP-1 receptor- Inodzvanya chishuwo, inononoka kubuda mudumbu, uye inovandudza insulin secretion

  • GIP receptor-Kuwedzera kunosimudzira kuburitswa kwe insulin uye inogonesa glucose metabolism

  • Glucagon receptor-Inowedzera basal metabolic rate, inosimudzira kuparara kwemafuta, uye inowedzera kushandiswa kwesimba

Iyi nzira ye "katatu-chiito" haingotsigire kuwedzera kuderera kwehuremu asiwo inovandudza akawanda ehutano hwemetabolism, kusanganisira glucose control, lipid profiles, uye kuderedza mafuta echiropa.

Inonakidza Early Clinical Results

Mukutanga miedzo yekiriniki, vanhu vasina chirwere cheshuga vane kufutisa vakatora Retatrutide kweanenge mavhiki e48 vakaona.avhareji yekurasikirwa nehuremu inopfuura 20%, nevamwe vatori vechikamu vanowana inenge 24%-kusvika pakubudirira kwekuvhiyiwa kwebariatric. Pakati pevanhu vane chirwere cheshuga cherudzi rwechipiri, mushonga hauna kungoderedza zvakanyanya mazinga eHbA1c asi zvakare wakaratidza mukana wekuvandudza moyo uye metabolic ngozi zvinhu.

Mikana uye Zvinetso Zviri Mberi

Nepo Retatrutide ichiratidza vimbiso inoshamisa, ichiri muchikamu chechitatu miedzo yekiriniki uye haifanirwe kusvika pamusika isati yasvika.2026–2027. Kana ichigona kunyatsoita "mutambo-kuchinja" zvinoenderana ne:

  1. Kuchengeteka kwenguva refu-Kutarisa kune mitsva kana yakawedzera mhedzisiro kana ichienzaniswa neiyo iripo GLP-1 mishonga

  2. Kushivirira uye kuomerera-Kuona kana kushanda kwepamusoro kunouya pamutengo wemitengo yepamusoro yekurega

  3. Commercial viability- Mitengo, kuvharwa kweinishuwarenzi, uye kusiyanisa kwakajeka kubva kune zvinokwikwidza zvigadzirwa

Inogona Kuitika Musika

Kana Retatrutide ichigona kuenzanisa chiyero pakati pekuchengetedza, kushanda nesimba, uye kukwanisa, inogona kuseta chiyero chitsva chemishonga yekuderedza uremu uye kusundira kufutisa uye kurapwa kwechirwere cheshuga munguva yemulti-chinangwa chakarurama kupindira-pamwe kugadziridza musika wese wepasi rose metabolic chirwere.


Nguva yekutumira: Aug-14-2025